Latest publications
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study
J Neurol, 2022. doi: 10.1007/s00415-022-11047-5
Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, Bernasconi MP, Castelnovo V, Cividini C, Cursi M, Vabanesi M, Impellizzeri M, Lazzarin SM, Fanelli GF, Minicucci F, Giacalone G, Falini A, Falautano M, Rovere-Querini P, Roveri L, Filippi M
Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study
J Neurol. 2020;1-5. doi:10.1007/s00415-020-09958-2
Cecchetti G, Vabanesi M, Chieffo R, et al.
Resting-state electroencephalographic biomarkers of Alzheimer’s Disease
Neuroimage Clin. 2021;31:102711. doi: 10.1016/j.nicl.2021.102711.
Cecchetti G, Agosta F, Basaia S, Cividini C, Cursi M, Santangelo R, Caso F, Minicucci F, Magnani G, Filippi M.
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer's disease
Eur J Neurol. 2021; Sep;28(9):2980-2988. doi: 10.1111/ene.14999
Santangelo R, Agosta F, Masi F, Spinelli EG, Cecchetti G, Caso F, Mandelli A, Cardamone R, Barbieri A, Furlan R, Magnani G, Filippi M.
Amyotrophic Lateral Sclerosis-Frontotemporal Dementia: Shared and Divergent Neural Correlates Across the Clinical Spectrum
Neurology, 2022. doi: 10.1212/WNL.0000000000013123
Camilla Cividini, Silvia Basaia, Edoardo G Spinelli, Elisa Canu, Veronica Castelnovo, Nilo Riva, Giordano Cecchetti, Francesca Caso, Giuseppe Magnani, Andrea Falini, Massimo Filippi, Federica Agosta,
CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI "imminent" converters to AD
Eur J Nucl Med Mol Imaging. 2020;10.1007/s00259-020-04853-4. doi:10.1007/s00259-020-04853-4
Santangelo R, Masserini F, Agosta F, Sala A, Caminiti SP, Cecchetti G, et al.
Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia
J Alzheimers Dis. 2016;54(4):1495-1508. doi:10.3233/JAD-160360
Mazzeo S, Santangelo R, Bernasconi MP, Cecchetti G, et al.
Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease
J Alzheimers Dis. 2017;60(1):183-200. doi:10.3233/JAD-170186
Santangelo R, Cecchetti G, Bernasconi MP, et al.
Primary progressive multiple sclerosis presenting with severe predominant cognitive impairment and psychiatric symptoms: A challenging case
Mult Scler. 2017;23(11):1558-1561. doi:10.1177/1352458517702550
Zambon AA, Cecchetti G, Caso F, et al.
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review
J Neurol. 2020;267(8):2462-2468. doi:10.1007/s00415-020-09988-w
Lazzarin SM, Vabanesi M, Cecchetti G, et al.
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an Expert Opinion and practical guidelines
Massimo Filippi, Giordano Cecchetti, Camillo Marra, Annachiara Cagnin, Flavio Nobili, Lucilla Parnetti, Federica Agosta.
